Sponsor or institution
Clinical trials and research at Aimmax Therapeutics, INC.
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $2.7 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
A new oral pill to treat drug-resistant gonorrhea
This project aims to create an oral antibiotic that can treat gonorrhea that no longer responds to current drugs and might also cover common chlamydia co-infections.
-
Creating a new oral antibiotic to treat drug-resistant gonorrhea
This study is testing a new oral antibiotic that aims to effectively treat drug-resistant gonorrhea and chlamydia in one easy-to-take pill, making it simpler for people to stick to their treatment and helping tackle the rising issue of antibiotic resistance.
-
Creating a new injectable antibiotic for serious drug-resistant infections
This study is testing a new antibiotic called AMX-2005 to see if it can help treat serious infections caused by tough bacteria like MRSA and VRE, giving hope to patients who need better options when current treatments don’t work.
-
Developing new antifungal peptides to fight resistant infections
This study is working on developing new treatments to help fight tough fungal infections, like invasive candidiasis, especially for patients who have infections that don't respond to current medicines.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.